Skip to content

Clinical trials

Liver Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Neoplasms Country / region: Germany Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20022
20031
20051
20061
20074
20082
20091
20101
20111
20131
20141
20152
20162
20175
20187
20195
20205
20214
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Terminated8
Active, not recruiting5
Recruiting5
Unknown status2
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer5
AstraZeneca4
Bristol-Myers Squibb4
Novartis Pharmaceuticals3
Auron Healthcare GmbH2
Charite University, Berlin, Germany2
FeRx2
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest2
University Hospital Tuebingen2
AIO-Studien-gGmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Neoplasms53
Carcinoma, Hepatocellular26
Cholangiocarcinoma8
Pancreatic Neoplasms8
Colorectal Neoplasms7
Esophageal Neoplasms7
Neoplasm Metastasis6
Stomach Neoplasms6
Breast Neoplasms5
Liver Diseases5

Trials

Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.